![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | C07J 9/00 | (2006.01) |
C07J 41/00 | (2006.01) | ||
A61K 31/575 | (2006.01) | ||
A61P 1/16 | (2006.01) | ||
C07J 71/00 | (2006.01) | ||
C07J 31/00 | (2006.01) |
(11) | Number of the document | 2997035 |
(13) | Kind of document | T |
(96) | European patent application number | 14723820.8 |
Date of filing the European patent application | 2014-05-14 | |
(97) | Date of publication of the European application | 2016-03-23 |
(45) | Date of publication and mention of the grant of the patent | 2018-03-28 |
(46) | Date of publication of the claims translation | 2018-08-10 |
(86) | Number | PCT/EP2014/059896 |
Date | 2014-05-14 |
(87) | Number | WO 2014/184271 |
Date | 2014-11-20 |
(30) | Number | Date | Country code |
201361823169 P | 2013-05-14 | US |
(72) |
PELLICCIARI, Roberto, IT
|
(73) |
Intercept Pharmaceuticals, Inc.,
10 Hudson Yards, 37th Floor, New York, NY 10001,
US
|
(74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
(54) | Tulžies rūgščių 11-hidroksil-6-pakeistieji dariniai ir aminorūgščių konjugatai kaip farnezoidų X receptoriaus moduliatoriai |
11-HYDROXYL-6-SUBSTITUTED-DERIVATIVES OF BILE ACIDS AND AMINO ACID CONJUGATES THEREOF AS FARNESOID X RECEPTOR MODULATORS |
Payment date | Validity (years) | Amount | |
2025-04-22 | 12 | 289.00 EUR |
2026-05-14 |